Results 91 to 100 of about 8,048 (135)

Role of Mediterranean Diet Adherence on Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease Patients. [PDF]

Biomolecules
Salomone L, Menichelli D, Cammisotto V, Castellani V, Pastori D, Pignatelli P, Mitterhofer AP, Tinti F, Lai S.   +8 more
europepmc   +1 more source

The Hidden Iceberg of ADPKD: Early Organomegaly-Driven Malnutrition and Sarcopenia Beyond Preserved eGFR. [PDF]

Int J Mol Sci
Brambilla Pisoni M, Catania M, Rivera RF, De Rosa LI, Kola K, Paolisi M, Bianca P, Farinone S, Petrone M, Citterio L, Vezzoli G, Sciarrone Alibrandi MT.   +11 more
europepmc   +1 more source

Effect of tolvaptan on the prognosis of patients with rapidly progressive autosomal dominant polycystic kidney disease: a prospective open-label study. [PDF]

Front Med (Lausanne)
Zhou L, Li W.
europepmc   +1 more source

The PKD Daily: Development and Content Validation of a Hybrid Diary for Tracking Urinary Events in Adults with Autosomal Dominant Polycystic Kidney Disease (ADPKD). [PDF]

Adv Ther
O'Connor M, Broderick L, Waldman LT, Costa E, Carty M, Nunna S, Oberdhan D.   +6 more
europepmc   +1 more source

Heterogeneous regulation of fibroblast growth factor 23 in acute kidney injury, chronic kidney disease, and polycystic kidney disease: mechanisms, diagnostic utility, and clinical implications. [PDF]

Front Mol Biosci
Hu X, Yang B, Chen H, Min M, Liu N, Xue C.   +5 more
europepmc   +1 more source

Patient-derived kidney organoids recapitulate ADPKD and facilitate the identification of Rho pathway inhibitors as candidate therapeutics. [PDF]

Cell Rep Med
Guo L, Fan Y, Sun H, Du H, Xiong H, Li Y, Zhang X, Guan Y, Ren L, Wang X, Chen K, An Y, Zhang X, Mao Y, Gong Y, Kong F, Qiu J, Chen R, Shi B, Yi F, Hu H, Zhao S.   +21 more
europepmc   +1 more source

Quantitative dynamic contrast-enhanced magnetic resonance imaging for renal perfusion measurement in autosomal dominant polycystic kidney disease. [PDF]

Quant Imaging Med Surg
Onuoha EE, Holland MD, Krishnan C, Mrug M, Kim H.   +4 more
europepmc   +1 more source

Real-World Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Nondiabetic Autosomal-Dominant Polycystic Kidney Disease: Effects on Progression to Dialysis in a TrinetX Cohort. [PDF]

Mayo Clin Proc Innov Qual Outcomes
Chang CH, Kuo YC, Kuan YH, Lim PS, Chung MC, Pan YR, Luo CW, Wu TK.   +7 more
europepmc   +1 more source